2011-01-04 00:00:00,Kiadis Pharma Signs License Agreement With
2011-02-02 00:00:00,Issues FY 2011 Guidance Below Estimates
2011-02-03 00:00:00,Announces FDA Approval Of Topotecan Injection
2011-03-08 00:00:00,Board Names Michael Ball New Christopher Begley to Assume Executive Chairman Role
2011-03-09 00:00:00,Announces Approval of Generic Docetaxel
2011-04-26 00:00:00,Reaffirms FY 2011 Guidance
2011-07-27 00:00:00,Raises FY 2011 Revenue Reaffirms FY 2011 EPS Guidance
2011-09-06 00:00:00,Announces Positive Results From Phase I Clinical Trial of Biosimilar Erythropoietin in Renal Patients
2011-10-18 00:00:00,Lowers FY 2011 EPS Guidance
2011-10-26 00:00:00,Lowers FY 2011 Revenue Reaffirms FY 2011 EPS Guidance
2012-02-14 00:00:00,Issues FY 2012 Mixed Guidance
2012-05-01 00:00:00,Reaffirms FY 2012 Guidance
2012-08-01 00:00:00,Hospira Inc Reaffirms FY 2012 Revenue Sees FY 2012 EPS Guidance At Low End Of Prior Range
2012-08-28 00:00:00,FDA Warns Hospira Inc Over Costa Rica Infusion Pump
2012-10-09 00:00:00,BASF adds fine chemical catalysts manufacturing in India
2012-10-24 00:00:00,Larry Robbins Grows in Tenet Healthcare Shares
2012-11-06 00:00:00,The Generics Empire Of Watson Pharma Soon To Be Named Actavis
